Brimonidine

Molecular formula: C16H14F3N3O2SMolecular weight: 369.36

Molecular formula: C11H9I3N2O4Molecular weight: 613.91

Selective inhibitor of phosphodiesterase V (PDE 5); potent coronary vasodilator drug; adenosine transport inhibitor; inhibitor of platelet aggregation.;Labeled Dipyridamole, intended for use as an internal standard for the quantification of Dipyridamole by GC- or LC-mass spectrometry.

Deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist.;Labeled Raloxifene, intended for use as an internal standard for the quantification of Raloxifene by GC- or LC-mass spectrometry.

Ranolazine is an anti-ischemic agent which modulates myocardial metabolism. Antianginal.

Labeled Propafenone, intended for use as an internal standard for the quantification of Propafenone by GC- or LC-mass spectrometry.

Potassium Trichloroammineplatinate is the degradation product of Cisplatin , an antitumor compound which exhibits mutagenic activity.;Impurity in commercial preparations of Cisplatin

A nonsteroidal, selective estrogen receptor modulator (SERM). Antiosteoporotic.

Labeled Tolterodine, intended for use as an internal standard for the quantification of Tolterodine by GC- or LC-mass spectrometry.

A dihydropyridine calcium channel blocker.;Labeled Lercanidipine, intended for use as an internal standard for the quantification of Lercanidipine by GC- or LC-mass spectrometry.

Impurity in commercial preparations of Candesartan.

Labeled Ezetimibe, intended for use as an internal standard for the quantification of Ezetimibe by GC- or LC-mass spectrometry.

Your Globally ''Trusted'' Partner for Reference Standards and Research Chemicals.